Moderna, Inc. (NASDAQ: MRNA) last traded at $213.74, down 5.00% on the session. The quote above updates while this page is open; the figures below are drawn from Moderna, Inc.’s own filings and are restated only when a new one is published.
Moderna, Inc. trades on NASDAQ under the ticker MRNA. It is classified in the Healthcare sector, Biotech industry. Its market capitalisation is $85.33 billion.
Healthcare sectorBiotechListed on NASDAQ
Valuation measures for Moderna, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $85.33B |
|---|---|
| Enterprise value | $87.81B |
| Price / sales | 38.30 |
| Price / book | 12.62 |
| Beta |
|---|
| 2.04 |
Trailing-twelve-month figures tagged in Moderna, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $2.23B |
|---|---|
| Net income (TTM) | -$3.15B |
| EPS (TTM) | -$7.98 |
| Gross margin | 23.38% |
| Operating margin | -149.01% |
| Return on equity | -46.61% |
| Cash | $1.72B |
Range and volume for MRNA over the past 52 weeks.
| 52-week high | $227.46 |
|---|---|
| 52-week low | $22.28 |
| Volume | 12.83M |
| Average volume | 18.18M |
| Previous close | $225.00 |
Other Healthcare companies tracked on FurlPay Markets.
Invest a chosen dollar amount in Moderna, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MRNA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.